Definitive Contract HHSO100201100012C
Award Date
2/24/11
Potential Completion Date
2/28/20
Potential Value
$203M
Awardee
Novavax Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Novavax Inc. (Novavax) is for vaccine development and production related to the COVID-19 response. The $36,042,001.44 definitive contract was awarded by the U.S. Army's Aberdeen Proving Ground Contracting Command. As a prime contractor, Novavax will deliver products and services out of its Maryland facility to aid Army medical research programs. Novavax also holds several Indefinite Delivery Vehicle (IDV) contracts to supply COVID-19 vaccines, including a $174...
This is a cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Vaxine PTY LTD, a for-profit organization located in Australia. The $18,541,473.00 contract is for the "ADVANCED DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES". The contract has an end date of August 14, 2023 and was initially awarded on September 20, 2018. This contract...
This is a $1,754,345,480.45 definitive cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Moderna, Inc. for the development of an mRNA vaccine to licensure for the prevention of COVID-19. The contract includes pre-award costs, development of the mRNA vaccine to Biologics License Application (BLA), and domestic manufacturing scale-out. This award does not have a set-aside designation. Moderna, a for-profit pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,097.08 firm fixed-price delivery order is for the supply of 4,566,251,281 units of the Novavax COVID-19 vaccine (0.5 mL) for the 2024-2025 period. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a federal contract award to Protein Sciences Corp, a for-profit vaccine manufacturer, by the U.S. Department of Health and Human Services' (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). The $2,146,389.00 firm fixed-price contract is a delivery order under ASPR's Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The purpose of the award is for Protein Sciences to manufacture 1 bulk lot of an H7 vaccine. No set-aside designation was...
This is a $35,019,405.00 firm fixed-price delivery order contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a foreign-owned, for-profit biotechnology company that specializes in pandemic preparedness and response. The purpose of the contract is to procure an influenza A(H2Nx) virus vaccine candidate(s) and conduct related clinical trials. This order is part of a larger $13.4 billion...
This definitive contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Moderna US, Inc. for COVID-19 vaccinations in support of the 2022 Fall Vaccine Campaign. The $7.8 billion firm fixed price contract is a transfer from the original awarding agency, the Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense, and represents continuation of vaccine production...
This is a $2,574,853.28 Firm Fixed Price contract awarded by the Department of the Army Medical Command to Technovax Inc., a Minority Owned, Self Certified Small Disadvantaged Business, for the "Next-Generation Adenovirus Vaccine" under the ARMY 15.1 SBIR (Small Business Innovation Research) program. The contract is set aside for Small Businesses and has a period of performance through March 31, 2023. The contract is associated with the National Interest Action Code for the Coronavirus...
This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 22 (VISN 22), a civilian agency within the U.S. Department of Veterans Affairs, to Novartis Vaccines and Diagnostics, Inc., a foreign-owned for-profit manufacturing company. The contract, valued at $197,600.00, is for the delivery of flu vaccines. The contract has an ultimate completion date of December 31, 2015 and does not have a set-aside designation. No information about major subcontractors...
This federal contract award, with ID SPE2DX15D3306|SPE2DX25FADJR, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,194.16 firm fixed-price delivery order is for the supply of 4566328847 NOVAVAX COVID 2024-25 SYR(EUA) 0.5ML vaccines, with an ultimate completion date of November 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...